Cannabidiol for chronic pain management is fastest growing segment fueling the growth of Cannabidiol Market
Cannabidiol Market |
The global Cannabidiol Market is
estimated to be valued at US$ 7953.14 Mn in 2023 and is expected to exhibit a
CAGR of 47% over the forecast period 2023 to 2030, as highlighted in a new
report published by Coherent Market Insights.
Market Overview:
Cannabidiol or CBD is a
non-psychoactive compound found in the Cannabis plant. CBD offers
therapeutically benefits in chronic pain, arthritis, anxiety, epilepsy, cancer
and other medical conditions. It has gained popularity as an effective
alternative treatment to opioids for pain management.
Market key trends:
One of the key trends in the
Cannabidiol market is its increasing demand for treatment of chronic pain.
Chronic pain affects more than 50 million adults in the U.S. annually.
Conventional pain treatments involve the use of opioids which are addictive and
can lead to dependency. CBD offers an effective alternative to opioids for
chronic pain management without any side effects. Studies have found CBD to be
effective in reducing arthritis pain and neuropathic pain. Its
anti-inflammatory properties help relieve pain associated with autoimmune
diseases. This has boosted its popularity as a natural remedy for pain relief.
Segment Analysis
The global cannabidiol market can
be segmented based on product type, application, distribution channel, and
region. By product type, the market can be segmented into pharmaceutical and
nutraceutical. The pharmaceutical segment dominates the market and is expected
to continue its dominance over the forecast period. This is attributed to
increased adoption of CBD-based pharmaceutical products for the treatment of
various medical conditions such as epilepsy, neurological disorders, anxiety,
depression and chronic pain.
Key Takeaways
The Global
Cannabidiol Market Size is
expected to witness high growth, exhibiting a CAGR of 47.% over the forecast
period, due to increasing legalization of cannabis-based products across various
regions.
Regional analysis
North America dominates the
global cannabidiol market and is expected to continue its dominance over the
forecast period. This is attributed to rising awareness about the medicinal
properties of cannabis in countries like US and Canada. Growing legalization of
both medical and recreational cannabis across various US states is also driving
the growth of the regional market.
Key players
Key players operating in the
cannabidiol market are Canopy Growth Corporation, Aphria, Inc., Aurora
Cannabis, Maricann, Inc., Tilray, GW Pharmaceuticals, plc, ABcann Medicinals,
Inc., Organigram Holding, Inc., Tikun Olam, The Cronos Group, ENDOCA, Isodiol
International, Inc., MEDICAL MARIJUANA, INC., Cannoid, LLC, Elixinol, Folium
Biosciences, NuLeaf Naturals, LLC, and Pharmahemp d.o.o.
Read more
https://www.dailyprbulletin.com/cannabidiol-market-size-share-growth-outlook-2023/
Comments
Post a Comment